ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$10.85
-0.78%
Mkt Cap $2.57B
Next Earnings
In 7 daysWed, May 6, 2026
EPS Estimate
$0.19
1 analysts
Revenue Estimate
$139.98M
Last quarter: beat by +8.11% on EPS, -0.31% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$2.57B
P/E
18.39
Fwd P/E
11.93
P/S
5.03
Rev TTM
—
EPS TTM
$0.60